An investigation of the role of the ErbB receptor family in chemotherapeutic drug resistance and invasion in human breast cancer
Sharon A. Glynn(Ollscoil na Gaillimhe – University of Galway)
Arrow@dit (Dublin Institute of Technology)
January 1, 2002
Cited by 0
Related Papers
The Role of Nitric Oxide in Cancer: Master Regulator or NOt?
|International Journal of Molecular Sciences|2020|171
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways
|Oncotarget|2017|89
COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer
|BMC Cancer|2010|79